Fri, March 11, 2022
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022
Sun, March 6, 2022
Fri, March 4, 2022
Thu, March 3, 2022

Joseph Schwartz Maintained (AUPH) at Buy with Decreased Target to $22 on, Mar 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-22-on-mar-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $30 to $22 on, Mar 8th, 2022.

Joseph has made no other calls on AUPH in the last 4 months.



There are 2 other peers that have a rating on AUPH. Out of the 2 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $27 on, Tuesday, March 1st, 2022
  • Justin Kim of "Oppenheimer" Upgraded from Hold to Buy and Decreased Target to $31 on, Friday, December 10th, 2021

Publication Contributing Sources